6-(Furan-3-yl)-1H-indole

Catalog No.: 
ACPLGR576
CAS No.: 
885273-05-2
Molecular Formula: 
C12H9NO
Molecular Weight: 
183.21
6-(Furan-3-yl)-1H-indole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$225.00InquiryInquiry
100mg95%$327.00InquiryInquiry
250mg95%$712.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name6-(Furan-3-yl)-1H-indole
IUPAC Name6-(furan-3-yl)-1H-indole
MDL No.-
Molecular FormulaC12H9NO
Molecular Weight183.21
SMILESC12=C(NC=C2)C=C(C3=COC=C3)C=C1
InChI KeySESUSXJVWJHEOW-UHFFFAOYSA-N
Synonym6-FURAN-3-YL-1H-INDOLE;1H-Indole, 6-(3-furanyl)-
CAS No.885273-05-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACPLGR576 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACXILH248 route compound structure diagram
    ACXILH24852415-29-9In Stock
  2. Plus
  3. ACSHLI790 route compound structure diagram
    ACSHLI79055552-70-0In Stock
  4. Then
  5. ACPLGR576 route product structure diagram
    ACPLGR576885273-05-2
Inquiry

2. ACPLGR576 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACWGIZ726 route compound structure diagram
    ACWGIZ726115666-47-2In Stock
  2. Plus
  3. ACSHLI790 route compound structure diagram
    ACSHLI79055552-70-0In Stock
  4. Then
  5. ACPLGR576 route product structure diagram
    ACPLGR576885273-05-2
Inquiry

3. ACPLGR576 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACXILH248 route compound structure diagram
    ACXILH24852415-29-9In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPLGR576 route product structure diagram
    ACPLGR576885273-05-2
Inquiry

Comments (0)